A Comprehensive Review of Clinical Features, Management and Homoeopathic Approach in Vitiligo
Main Article Content
Abstract
Vitiligo, as a problem, is a source of great embarrassment to people. Vitiligo, is a common chronic condition characterized by cutaneous depigmention , in which melanocytes are selectively lost, resulting in non-scaly, chalky-white macules. There is no specific ethnic group, gender, or skin type that is more prone to vitiligo than others, it can affect anyone. This review is aimed to provide a comprehensive knowledge about the current state of vitiligo. vitiligo is typically thought as a cosmetic disorder which effects physical and psychosocial health of sufferers that cannot be ignored.
Article Details
References
A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Gauthier Y, Cario Andre M, Taïeb A. Pigment Cell Res. 2003;16:322–332. doi: 10.1034/j.1600-0749.2003.00070.x. [DOI] [PubMed] [Google Scholar]
Prasad, P.V.; Bhatnagar, V.K. Medico-historical study of “Kilasa”(vitiligo/leucoderma) a common skin disorder. Bull. Indian Inst. Hist. Med. 2003, 33, 113–127. [Google Scholar]
Czajkowski, R.; Męcińska-Jundziłł, K. Current aspects of vitiligo genetics. Adv. Dermatol. Allergol. Postępy Dermatol. I Alergol. 2014, 31, 247–255. [Google Scholar] [CrossRef] [PubMed]
A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Krüger C, Schallreuter KU. Int J Dermatol. 2012;51:1206–1212. doi: 10.1111/j.1365-4632.2011.05377.x. [DOI] [PubMed] [Google Scholar]
Mohr, N.; Petersen, J.; Kirsten, N.; Augustin, M. Epidemiology of Vitiligo–A Dual Population-Based Approach. Clin. Epidemiol. 2021, 13, 373–382. [Google Scholar] [CrossRef] [PubMed]
Alikhan, A.; Felsten, L.M.; Daly, M.; Petronic-Rosic, V. Vitiligo: A comprehensive overview: Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J. Am. Acad. Dermatol. 2011, 65, 473–491. [Google Scholar] [CrossRef]
Nejad, S.B.; Qadim, H.H.; Nazeman, L.; Fadaii, R.; Goldust, M. Frequency of autoimmune diseases in those suffering from vitiligo in comparison with normal population. Pak. J. Biol. Sci. PJBS 2013, 16, 570–574. [Google Scholar] [CrossRef]
Hann, S.K.; Lee, H.J. Segmental vitiligo: Clinical findings in 208 patients. J. Am. Acad. Dermatol. 1996, 35, 671–674. [Google Scholar] [CrossRef]
Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitiligo vulgaris: An open label pilot clinical trial. BMC Complement Altern Med 2011;11:21 Available from: http://www.biomedcentral. com/1472-6882/11/21. [Last accessed on 2017 Jun 25].
Mazzei Weiss ME. Vitiligo: to biopsy or not to biopsy? Cutis. 2020 Apr;105(4):189-190. [PubMed]
Current and emerging treatments for vitiligo. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. J Am Acad Dermatol. 2017;77:17–29. doi: 10.1016/j.jaad.2016.11.010. [DOI] [PubMed] [Google Scholar]
Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology. 2020;236(6):571-592. [PubMed]
Henning SW, Jaishankar D, Barse LW, Dellacecca ER, Lancki N, Webb K, Janusek L, Mathews HL, Price RN, Le Poole IC. The relationship between stress and vitiligo: Evaluating perceived stress and electronic medical record data. PLoS One. 2020;15(1):e0227909. [PMC free article] [PubMed]
Understading the symptoms of vitiligo; Medically reviewed by Raechele Cochran Gathers, MD — Written by Yvette Brazier and Stephanie A. Wright, RN, BSN — Updated on October 1, 2023.
Innervation of melanocytes in human skin. Hara M, Toyoda M, Yaar M, Bhawan J, Avila EM, Penner IR, Gilchrest BA. J Exp Med. 1996;184:1385–1395. doi: 10.1084/jem.184.4.1385. [DOI] [PMC free article] [PubMed] [Google Scholar]
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions. Slominski A, Zmijewski MA, Pawelek J. Pigment Cell Melanoma Res. 2012;25:14–27. doi: 10.1111/j.1755-148X.2011.00898.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site. van den Wijngaard R, Wankowicz-Kalinska A, Le Poole C, Tigges B, Westerhof W, Das P. Lab Invest. 2000;80:1299–1309. doi: 10.1038/labinvest.3780138. [DOI] [PubMed] [Google Scholar]
Lakhani, R.; Prakash, C.; Tiwari, S.; Purohit, S.; Paliwal, V.; Mathur, D.K.; Bhargava, P. Scoring system in dermatology: A review. IOSR 2016, 15, 89–99. [Google Scholar] [CrossRef]
Cohen BE, Manga P, Lin K, Elbuluk N. Vitiligo and Melanoma-Associated Vitiligo: Understanding Their Similarities and Differences. Am J Clin Dermatol. 2020 Oct;21(5):669-680. [PubMed]
Douglass MF. Skin Diseases. Delhi: World Homoeopathic Links; 1899. p. 379-82. 10.
Bernstein R. Homoeopathy, Elementary Dermatology; New Delhi, India BJain Publishers, 2003; 187-89 11
. Lilienthals S. A Treatise on Diseases of the Skin. New Delhi, India: B. Jain Publishers; 2002. p. 113-7. 12.
Kichlu KL. Descriptive Medicine with Clinical Methods & Homoeopathic Therapeutics. New Delhi, India: B Jain Publishers; 1999. p. 694. 13.
Boericke W. Boericke’s New Manual of Homeopathic Materia Medica with Repertory.New Delhi, India, B. jain Publishers; 2010. p. 885.